ALPHA STAR ACQUISITION CORPORATION - RIGHTS
0.1185
31-October-24 14:14:00
15 minutes delayed
Stocks
+0.0185
+18.50%
Today's range
0.1185 - 0.1200
ISIN
N/A
Source
NASDAQ
-
Luminar Technologies (NASDAQ:LAZR) Shares Gap Down on Analyst Downgrade
15 Nov 2024 10:56:19 By Buzz FX
-
Sally Beauty (NYSE:SBH) Hits New 52-Week High After Analyst Upgrade
15 Nov 2024 10:56:19 By Buzz FX
-
EchoStar (NASDAQ:SATS) Shares Gap Up Following Insider Buying Activity
15 Nov 2024 10:56:19 By Buzz FX
-
Hut 8 (NASDAQ:HUT) Trading Up 3.8% on Analyst Upgrade
15 Nov 2024 10:56:19 By Buzz FX
-
Gambling.com Group (NASDAQ:GAMB) Receives Buy Rating from Truist Financial
15 Nov 2024 10:56:19 By Buzz FX
-
Elastic (NYSE:ESTC) Given New $105.00 Price Target at Barclays
15 Nov 2024 10:56:19 By Buzz FX
-
Annexon's (ANNX) Overweight Rating Reiterated at Cantor Fitzgerald
15 Nov 2024 10:56:19 By Buzz FX
-
Life360 (NASDAQ:LIF) Sees Strong Trading Volume on Analyst Upgrade
15 Nov 2024 10:56:19 By Buzz FX
-
AdaptHealth (NASDAQ:AHCO) Price Target Lowered to $12.00 at Truist Financial
15 Nov 2024 10:56:19 By Buzz FX
-
Codexis (NASDAQ:CDXS) Given Overweight Rating at Cantor Fitzgerald
15 Nov 2024 10:56:19 By Buzz FX
-
Barclays Forecasts Strong Price Appreciation for Couchbase (NASDAQ:BASE) Stock
15 Nov 2024 10:56:19 By Buzz FX
-
Perpetua Resources (NASDAQ:PPTA) Shares Gap Up on Analyst Upgrade
15 Nov 2024 10:56:19 By Buzz FX
-
Enlight Renewable Energy (NASDAQ:ENLT) Price Target Raised to $21.00 at Barclays
15 Nov 2024 10:56:19 By Buzz FX
-
Guardian Pharmacy Services (NYSE:GRDN) Price Target Raised to $24.00
15 Nov 2024 10:56:19 By Buzz FX
-
ESCO Technologies (NYSE:ESE) Given "Buy" Rating at Benchmark
15 Nov 2024 10:56:19 By Buzz FX
-
BrightView (NYSE:BV) Shares Gap Up on Analyst Upgrade
15 Nov 2024 10:56:19 By Buzz FX
-
Donegal Group (NASDAQ:DGICA) Sets New 1-Year High After Insider Buying Activity
15 Nov 2024 10:56:19 By Buzz FX
-
Barclays Boosts Ovintiv (NYSE:OVV) Price Target to $57.00
15 Nov 2024 10:56:19 By Buzz FX
-
Barclays Boosts Intuit (NASDAQ:INTU) Price Target to $800.00
15 Nov 2024 10:56:19 By Buzz FX
-
BioMarin Pharmaceutical (NASDAQ:BMRN) Reaches New 1-Year Low on Insider Selling
15 Nov 2024 10:56:19 By Buzz FX